Remove 2010 Remove Leads Remove Pharma Remove Physicians
article thumbnail

Leading innovators in periodontitis drugs for the pharmaceutical industry

Pharmaceutical Technology

Innovation S-curve for the pharmaceutical industry Periodontitis drugs is a notable innovation area in the pharmaceutical industry Periodontal diseases, which may lead to the damage of teeth or bone, are caused by infections and inflammation of the gums and bone that surround and support the teeth.

Leads 52
article thumbnail

American health is in for a “world of hurt”

World of DTC Marketing

Cardiovascular disease deaths in the US have increased by nearly 17% since 2010, and are among the reasons that life expectancy in the U.S. has also seen reversals in health improvements since 2010, partly due to increasing rates of obesity, high blood pressure, and high blood sugar. . is lower than in other high-income countries.

Insurance 190
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Comparison of Humira biosimilars in the US and Europe

Pharmaceutical Technology

Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. Many pharma companies hold extensive patent protections and have ongoing patent litigation cases. The primary reasons for delayed market entry in the US revolve around patent disputes.

article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

In 2023, Humana’s care delivery component CenterWell launched a senior-centered “ Primary Care Anywhere ” program for in-home primary care in Georgia and Louisiana (where Humana leads the MA sectors) and increased senior membership in value-based home care models nationwide to more than 840,000.

Retail 52
article thumbnail

Exploring How COVID-19 Has Accelerated Digital in Healthcare: A Re-cap of the PMN Innovation Summit

Pharma Marketing Network

Quickly adapting to a new reality due to the COVID-19 pandemic was a theme throughout this year’s Pharma Marketing Network Innovation Summit 2021, linking all three panels: “ Telehealth: Past. Success in pharma marketing with telehealth. Amy Turnquist, PMN EAB Member, and Principal at North Highland lead this insightful panel.

article thumbnail

Exploring How COVID-19 Has Accelerated Digital in Healthcare: A Re-cap of the PMN Innovation Summit

Pharma Marketing Network

Quickly adapting to a new reality due to the COVID-19 pandemic was a theme throughout this year’s Pharma Marketing Network Innovation Summit 2021, linking all three panels: “ Telehealth: Past. Success in pharma marketing with telehealth. Amy Turnquist, PMN EAB Member, and Principal at North Highland lead this insightful panel.

article thumbnail

The traditional pharmaceutical commercialization model is outdated

Clarify Health

The panel included Bhash Parasuraman, PhD, Vice President and BU Lead, Rare Disease Patient & Health Impact, Pfizer , Calum MacRae, MD, PhD, Professor of Medicine at Harvard Medical School , and Surya Singh, MD, President, Singh Healthcare Advisors. A pay-for-outcomes contract between a payer and a pharma company needs to be adjudicated.